Milan Mishkovikj: A Game-Changing Moment in the Future of Hepatology
Milan Mishkovikj, Board Director at ELPA and President ‘National Alliance of Patient Organizations’ – NAPO, shared a post on LinkedIn:
“A Game-Changing Moment in the Future of Hepatology!
The EASL SLD Summit 2025 has officially arrived, and I’m thrilled to embark on this transformative journey alongside EASL Executive Director Ben Hainsworth! Over the next few days, we will delve into the intricate and evolving realm of Steatotic Liver Disease (SLD) (risk factors for Liver Cancer) —uniting cutting-edge science with real-world clinical solutions to transform lives.
What makes this summit extraordinary?
It’s an unparalleled deep dive into:
“The trajectory of people living with Steatotic Liver Disease.”_ A clinical update and consensus summit focused on pivotal topics like MASLD, MetALD, and ALD (alcohol liver disease) in Phase 2 and 3 clinical trials (Hope).
From the latest research breakthroughs to actionable strategies for patient care, this summit equips us with a 360-degree understanding of SLD. It’s where innovation meets compassion—bridging the gap between scientific advancement and patient advocacy.
This is a powerful collaboration between ELPA (patients) and EASL (scientists) – two pillars of European hepatology joining forces to reshape the landscape of liver health through revolutionary tools, insights, and partnerships. Together, we are setting a new standard for patient-centered care and pushing the boundaries of what’s possible.
Why does this matter?
Because it’s more than a summit—it’s a testament to the power of partnerships, the spirit of innovation, and the collective vision for better health worldwide. This summit is a beacon of hope and progress, driving us closer to a future where liver diseases no longer claim lives prematurely.
This is our moment to shine! Over the coming days, prepare for inspirational stories, transformative ideas, and groundbreaking discoveries that will echo far beyond the walls of this summit.
Together, we are not just participating in history – we are making it. Let’s create a future where liver health is a priority for all.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023